The Nocturnal Impact
Most medical device startups don’t fail because the idea was wrong.
They fail because execution breaks down.
Costs become unpredictable, scope creeps, data decisions are made too late, and teams spend precious time fixing problems that could have been avoided.
Nocturnal’s business model is designed to change this trajectory.
“Nocturnal greatly contributed to the development of our ground-breaking implantable device.”
David Prutchi, Ph.D., CTO & Executive VP, Impulse Dynamics
What changes when Nocturnal becomes part of the team?
Nocturnal works as an extension of your core team, which means that you always have full, real-time visibility to our work. We are a small team so you always work directly with our best and brightest, because that’s all we have.
Design, engineering, and data strategy are aligned from day one with clinical objectives, regulatory requirements, and manufacturing constraints —all while aiming for the safest path towards your next funding milestone.
How does Nocturnal reduce risk for startups?
“Been there done that” does make a difference when it comes to complex class II and class III device development.
We focus relentlessly on the risks that actually kill programs:
Runaway costs that deplete funding before reaching proof
Architectures that collapse when moving toward manufacturing
Data that can’t support AI, clinical, or regulatory needs
By addressing these risks early, teams avoid expensive redesigns and confidence-eroding delays.
What impact does Nocturnal have on startup success?
Across multiple programs and generations of devices, Nocturnal has helped teams reach critical milestones with fewer surprises—from prototype and MVP to clinical trials and commercialization.
- Greater confidence in technical decisions
- Predictable use of capital
- Faster transitions between phases
The impact isn’t just a working device—it’s a more resilient startup and stronger positioning with investors, partners, and regulators.
